Zentalis Pharmaceuticals, Inc. (ZNTL)
NASDAQ: ZNTL · Real-Time Price · USD
2.320
-0.150 (-6.07%)
At close: Feb 21, 2025, 4:00 PM
2.280
-0.040 (-1.72%)
After-hours: Feb 21, 2025, 7:32 PM EST

Zentalis Pharmaceuticals Stock Forecast

Stock Price Forecast

The 8 analysts with 12-month price forecasts for Zentalis Pharmaceuticals stock have an average target of 8.53, with a low estimate of 2.20 and a high estimate of 20. The average target predicts an increase of 267.67% from the current stock price of 2.32.

Analyst Consensus: Buy
Target Low Average Median High
Price $2.20 $8.53 $8.00 $20
Change -5.17% +267.67% +244.83% +762.07%

Analyst Ratings

The average analyst rating for Zentalis Pharmaceuticals stock from 8 stock analysts is "Buy". This means that analysts believe this stock is likely to outperform the market over the next twelve months.

Recommendation Trends

Rating Sep '24Oct '24Nov '24Dec '24Jan '25Feb '25
Strong Buy 223333
Buy 111111
Hold 444444
Sell 000000
Strong Sell 000000
Total 778888

Latest Forecasts

Analyst Firm Rating Rating Action Price Target Upside Date
Wells Fargo
Wells Fargo
Hold
Maintains
$8$6
Hold Maintains $8$6 +158.62% Jan 30, 2025
HC Wainwright & Co.
HC Wainwright & Co.
Strong Buy
Maintains
$20$10
Strong Buy Maintains $20$10 +331.03% Jan 29, 2025
UBS
UBS
Hold
Maintains
$5$2.2
Hold Maintains $5$2.2 -5.17% Jan 28, 2025
Guggenheim
Guggenheim
Strong Buy
Maintains
$12$8
Strong Buy Maintains $12$8 +244.83% Nov 15, 2024
HC Wainwright & Co.
HC Wainwright & Co.
Strong Buy
Reiterates
$20
Strong Buy Reiterates $20 +762.07% Nov 15, 2024
More Analyst Ratings

Financial Forecast

Revenue This Year
37.34M
Revenue Next Year
n/a
from 37.34M
EPS This Year
-2.45
from -4.47
EPS Next Year
-2.61
from -2.45
Fiscal Year FY 2019 FY 2020 FY 2021 FY 2022 FY 2023 FY 2024 FY 2025 FY 2026
Period Ending Dec 31, 2019 Dec 31, 2020 Dec 31, 2021 Dec 31, 2022 Dec 31, 2023 Dec 31, 2024 Dec 31, 2025 Dec 31, 2026
Revenue
-----37.34M-20.87M
Revenue Growth
--------
EPS
-8.16-4.19-3.72-4.48-4.47-2.45-2.61-2.54
EPS Growth
--------
Forward PE
--------
No. Analysts -----131313
Historical EPS numbers are GAAP, while forecasted numbers may be non-GAAP.

Revenue Forecast

Revenue 202420252026202720282029
High 43.1M n/a 177.6M
Avg 37.3M n/a 20.9M
Low n/a n/a n/a

Revenue Growth

Revenue Growth 202420252026202720282029
High - - -
Avg - - -
Low - - -

EPS Forecast

EPS 202420252026202720282029
High -2.36 -1.73 -1.71
Avg -2.45 -2.61 -2.54
Low -2.61 -3.25 -3.53

EPS Growth

EPS Growth 202420252026202720282029
High - - -
Avg - - -
Low - - -
Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.